Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

NCT06747520 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency

Interventions

DRUG: ET-26HCl

Sponsor

Ahon Pharmaceutical Co., Ltd.